COVID-19 Impact on Global Companion Diagnostic Tests Market Size, Status and Forecast 2020-2026

September 2020 | 90 pages | ID: C74F9FCB9D8CEN
QYResearch

Abstracts

This report focuses on the global Companion Diagnostic Tests status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Companion Diagnostic Tests development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• F. Hoffman LA Roche Ltd.
• QIAGEN, Illumina, Inc.
• Abbott
• Agilent Technologies, Inc.
• Genomic Health, Inc.
• BioMerieux SA, BioGenex
• AGENDIA NV
• Siemens Healthcare GmBH
• Thermo Fisher Scientific, Inc.

Market segment by Type, the product can be split into

• Protein Detection
• DNA Detection
• Hybridization
• Biomarker
• Others

Market segment by Application, split into

• Pharmaceutical and Biotechnology Companies
• Medical Device Companies
• Research Institutes

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Companion Diagnostic Tests status, future forecast, growth opportunity, key market and key players.
• To present the Companion Diagnostic Tests development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Companion Diagnostic Tests are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Companion Diagnostic Tests Revenue
1.4 Market Analysis by Type
  1.4.1 Global Companion Diagnostic Tests Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Protein Detection
  1.4.3 DNA Detection
  1.4.4 Hybridization
  1.4.5 Biomarker
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Companion Diagnostic Tests Market Share by Application: 2020 VS 2026
  1.5.2 Pharmaceutical and Biotechnology Companies
  1.5.3 Medical Device Companies
  1.5.4 Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Companion Diagnostic Tests Industry Impact
  1.6.1 How the Covid-19 is Affecting the Companion Diagnostic Tests Industry
    1.6.1.1 Companion Diagnostic Tests Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Companion Diagnostic Tests Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Companion Diagnostic Tests Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Companion Diagnostic Tests Market Perspective (2015-2026)
2.2 Companion Diagnostic Tests Growth Trends by Regions
  2.2.1 Companion Diagnostic Tests Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Companion Diagnostic Tests Historic Market Share by Regions (2015-2020)
  2.2.3 Companion Diagnostic Tests Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Companion Diagnostic Tests Market Growth Strategy
  2.3.6 Primary Interviews with Key Companion Diagnostic Tests Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Companion Diagnostic Tests Players by Market Size
  3.1.1 Global Top Companion Diagnostic Tests Players by Revenue (2015-2020)
  3.1.2 Global Companion Diagnostic Tests Revenue Market Share by Players (2015-2020)
  3.1.3 Global Companion Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Companion Diagnostic Tests Market Concentration Ratio
  3.2.1 Global Companion Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests Revenue in 2019
3.3 Companion Diagnostic Tests Key Players Head office and Area Served
3.4 Key Players Companion Diagnostic Tests Product Solution and Service
3.5 Date of Enter into Companion Diagnostic Tests Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Companion Diagnostic Tests Historic Market Size by Type (2015-2020)
4.2 Global Companion Diagnostic Tests Forecasted Market Size by Type (2021-2026)

5 COMPANION DIAGNOSTIC TESTS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Companion Diagnostic Tests Market Size by Application (2015-2020)
5.2 Global Companion Diagnostic Tests Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Companion Diagnostic Tests Market Size (2015-2020)
6.2 Companion Diagnostic Tests Key Players in North America (2019-2020)
6.3 North America Companion Diagnostic Tests Market Size by Type (2015-2020)
6.4 North America Companion Diagnostic Tests Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Companion Diagnostic Tests Market Size (2015-2020)
7.2 Companion Diagnostic Tests Key Players in Europe (2019-2020)
7.3 Europe Companion Diagnostic Tests Market Size by Type (2015-2020)
7.4 Europe Companion Diagnostic Tests Market Size by Application (2015-2020)

8 CHINA

8.1 China Companion Diagnostic Tests Market Size (2015-2020)
8.2 Companion Diagnostic Tests Key Players in China (2019-2020)
8.3 China Companion Diagnostic Tests Market Size by Type (2015-2020)
8.4 China Companion Diagnostic Tests Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Companion Diagnostic Tests Market Size (2015-2020)
9.2 Companion Diagnostic Tests Key Players in Japan (2019-2020)
9.3 Japan Companion Diagnostic Tests Market Size by Type (2015-2020)
9.4 Japan Companion Diagnostic Tests Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Companion Diagnostic Tests Market Size (2015-2020)
10.2 Companion Diagnostic Tests Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Companion Diagnostic Tests Market Size by Type (2015-2020)
10.4 Southeast Asia Companion Diagnostic Tests Market Size by Application (2015-2020)

11 INDIA

11.1 India Companion Diagnostic Tests Market Size (2015-2020)
11.2 Companion Diagnostic Tests Key Players in India (2019-2020)
11.3 India Companion Diagnostic Tests Market Size by Type (2015-2020)
11.4 India Companion Diagnostic Tests Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Companion Diagnostic Tests Market Size (2015-2020)
12.2 Companion Diagnostic Tests Key Players in Central & South America (2019-2020)
12.3 Central & South America Companion Diagnostic Tests Market Size by Type (2015-2020)
12.4 Central & South America Companion Diagnostic Tests Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 F. Hoffman LA Roche Ltd.
  13.1.1 F. Hoffman LA Roche Ltd. Company Details
  13.1.2 F. Hoffman LA Roche Ltd. Business Overview and Its Total Revenue
  13.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Introduction
  13.1.4 F. Hoffman LA Roche Ltd. Revenue in Companion Diagnostic Tests Business (2015-2020))
  13.1.5 F. Hoffman LA Roche Ltd. Recent Development
13.2 QIAGEN, Illumina, Inc.
  13.2.1 QIAGEN, Illumina, Inc. Company Details
  13.2.2 QIAGEN, Illumina, Inc. Business Overview and Its Total Revenue
  13.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Introduction
  13.2.4 QIAGEN, Illumina, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
  13.2.5 QIAGEN, Illumina, Inc. Recent Development
13.3 Abbott
  13.3.1 Abbott Company Details
  13.3.2 Abbott Business Overview and Its Total Revenue
  13.3.3 Abbott Companion Diagnostic Tests Introduction
  13.3.4 Abbott Revenue in Companion Diagnostic Tests Business (2015-2020)
  13.3.5 Abbott Recent Development
13.4 Agilent Technologies, Inc.
  13.4.1 Agilent Technologies, Inc. Company Details
  13.4.2 Agilent Technologies, Inc. Business Overview and Its Total Revenue
  13.4.3 Agilent Technologies, Inc. Companion Diagnostic Tests Introduction
  13.4.4 Agilent Technologies, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
  13.4.5 Agilent Technologies, Inc. Recent Development
13.5 Genomic Health, Inc.
  13.5.1 Genomic Health, Inc. Company Details
  13.5.2 Genomic Health, Inc. Business Overview and Its Total Revenue
  13.5.3 Genomic Health, Inc. Companion Diagnostic Tests Introduction
  13.5.4 Genomic Health, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
  13.5.5 Genomic Health, Inc. Recent Development
13.6 BioMerieux SA, BioGenex
  13.6.1 BioMerieux SA, BioGenex Company Details
  13.6.2 BioMerieux SA, BioGenex Business Overview and Its Total Revenue
  13.6.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Introduction
  13.6.4 BioMerieux SA, BioGenex Revenue in Companion Diagnostic Tests Business (2015-2020)
  13.6.5 BioMerieux SA, BioGenex Recent Development
13.7 AGENDIA NV
  13.7.1 AGENDIA NV Company Details
  13.7.2 AGENDIA NV Business Overview and Its Total Revenue
  13.7.3 AGENDIA NV Companion Diagnostic Tests Introduction
  13.7.4 AGENDIA NV Revenue in Companion Diagnostic Tests Business (2015-2020)
  13.7.5 AGENDIA NV Recent Development
13.8 Siemens Healthcare GmBH
  13.8.1 Siemens Healthcare GmBH Company Details
  13.8.2 Siemens Healthcare GmBH Business Overview and Its Total Revenue
  13.8.3 Siemens Healthcare GmBH Companion Diagnostic Tests Introduction
  13.8.4 Siemens Healthcare GmBH Revenue in Companion Diagnostic Tests Business (2015-2020)
  13.8.5 Siemens Healthcare GmBH Recent Development
13.9 Thermo Fisher Scientific, Inc.
  13.9.1 Thermo Fisher Scientific, Inc. Company Details
  13.9.2 Thermo Fisher Scientific, Inc. Business Overview and Its Total Revenue
  13.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Introduction
  13.9.4 Thermo Fisher Scientific, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020)
  13.9.5 Thermo Fisher Scientific, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Companion Diagnostic Tests Key Market Segments
Table 2. Key Players Covered: Ranking by Companion Diagnostic Tests Revenue
Table 3. Ranking of Global Top Companion Diagnostic Tests Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Companion Diagnostic Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Protein Detection
Table 6. Key Players of DNA Detection
Table 7. Key Players of Hybridization
Table 8. Key Players of Biomarker
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Companion Diagnostic Tests Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Companion Diagnostic Tests Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Companion Diagnostic Tests Players to Combat Covid-19 Impact
Table 15. Global Companion Diagnostic Tests Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Companion Diagnostic Tests Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Companion Diagnostic Tests Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Companion Diagnostic Tests Market Share by Regions (2015-2020)
Table 19. Global Companion Diagnostic Tests Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Companion Diagnostic Tests Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Companion Diagnostic Tests Market Growth Strategy
Table 25. Main Points Interviewed from Key Companion Diagnostic Tests Players
Table 26. Global Companion Diagnostic Tests Revenue by Players (2015-2020) (Million US$)
Table 27. Global Companion Diagnostic Tests Market Share by Players (2015-2020)
Table 28. Global Top Companion Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests as of 2019)
Table 29. Global Companion Diagnostic Tests by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Companion Diagnostic Tests Product Solution and Service
Table 32. Date of Enter into Companion Diagnostic Tests Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Companion Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 35. Global Companion Diagnostic Tests Market Size Share by Type (2015-2020)
Table 36. Global Companion Diagnostic Tests Revenue Market Share by Type (2021-2026)
Table 37. Global Companion Diagnostic Tests Market Size Share by Application (2015-2020)
Table 38. Global Companion Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 39. Global Companion Diagnostic Tests Market Size Share by Application (2021-2026)
Table 40. North America Key Players Companion Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Companion Diagnostic Tests Market Share (2019-2020)
Table 42. North America Companion Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 43. North America Companion Diagnostic Tests Market Share by Type (2015-2020)
Table 44. North America Companion Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 45. North America Companion Diagnostic Tests Market Share by Application (2015-2020)
Table 46. Europe Key Players Companion Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Companion Diagnostic Tests Market Share (2019-2020)
Table 48. Europe Companion Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Companion Diagnostic Tests Market Share by Type (2015-2020)
Table 50. Europe Companion Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Companion Diagnostic Tests Market Share by Application (2015-2020)
Table 52. China Key Players Companion Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 53. China Key Players Companion Diagnostic Tests Market Share (2019-2020)
Table 54. China Companion Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 55. China Companion Diagnostic Tests Market Share by Type (2015-2020)
Table 56. China Companion Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 57. China Companion Diagnostic Tests Market Share by Application (2015-2020)
Table 58. Japan Key Players Companion Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Companion Diagnostic Tests Market Share (2019-2020)
Table 60. Japan Companion Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Companion Diagnostic Tests Market Share by Type (2015-2020)
Table 62. Japan Companion Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Companion Diagnostic Tests Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Companion Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Companion Diagnostic Tests Market Share (2019-2020)
Table 66. Southeast Asia Companion Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Companion Diagnostic Tests Market Share by Type (2015-2020)
Table 68. Southeast Asia Companion Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Companion Diagnostic Tests Market Share by Application (2015-2020)
Table 70. India Key Players Companion Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 71. India Key Players Companion Diagnostic Tests Market Share (2019-2020)
Table 72. India Companion Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 73. India Companion Diagnostic Tests Market Share by Type (2015-2020)
Table 74. India Companion Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 75. India Companion Diagnostic Tests Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Companion Diagnostic Tests Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Companion Diagnostic Tests Market Share (2019-2020)
Table 78. Central & South America Companion Diagnostic Tests Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Companion Diagnostic Tests Market Share by Type (2015-2020)
Table 80. Central & South America Companion Diagnostic Tests Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Companion Diagnostic Tests Market Share by Application (2015-2020)
Table 82. F. Hoffman LA Roche Ltd. Company Details
Table 83. F. Hoffman LA Roche Ltd. Business Overview
Table 84. F. Hoffman LA Roche Ltd. Product
Table 85. F. Hoffman LA Roche Ltd. Revenue in Companion Diagnostic Tests Business (2015-2020) (Million US$)
Table 86. F. Hoffman LA Roche Ltd. Recent Development
Table 87. QIAGEN, Illumina, Inc. Company Details
Table 88. QIAGEN, Illumina, Inc. Business Overview
Table 89. QIAGEN, Illumina, Inc. Product
Table 90. QIAGEN, Illumina, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020) (Million US$)
Table 91. QIAGEN, Illumina, Inc. Recent Development
Table 92. Abbott Company Details
Table 93. Abbott Business Overview
Table 94. Abbott Product
Table 95. Abbott Revenue in Companion Diagnostic Tests Business (2015-2020) (Million US$)
Table 96. Abbott Recent Development
Table 97. Agilent Technologies, Inc. Company Details
Table 98. Agilent Technologies, Inc. Business Overview
Table 99. Agilent Technologies, Inc. Product
Table 100. Agilent Technologies, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020) (Million US$)
Table 101. Agilent Technologies, Inc. Recent Development
Table 102. Genomic Health, Inc. Company Details
Table 103. Genomic Health, Inc. Business Overview
Table 104. Genomic Health, Inc. Product
Table 105. Genomic Health, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020) (Million US$)
Table 106. Genomic Health, Inc. Recent Development
Table 107. BioMerieux SA, BioGenex Company Details
Table 108. BioMerieux SA, BioGenex Business Overview
Table 109. BioMerieux SA, BioGenex Product
Table 110. BioMerieux SA, BioGenex Revenue in Companion Diagnostic Tests Business (2015-2020) (Million US$)
Table 111. BioMerieux SA, BioGenex Recent Development
Table 112. AGENDIA NV Company Details
Table 113. AGENDIA NV Business Overview
Table 114. AGENDIA NV Product
Table 115. AGENDIA NV Revenue in Companion Diagnostic Tests Business (2015-2020) (Million US$)
Table 116. AGENDIA NV Recent Development
Table 117. Siemens Healthcare GmBH Business Overview
Table 118. Siemens Healthcare GmBH Product
Table 119. Siemens Healthcare GmBH Company Details
Table 120. Siemens Healthcare GmBH Revenue in Companion Diagnostic Tests Business (2015-2020) (Million US$)
Table 121. Siemens Healthcare GmBH Recent Development
Table 122. Thermo Fisher Scientific, Inc. Company Details
Table 123. Thermo Fisher Scientific, Inc. Business Overview
Table 124. Thermo Fisher Scientific, Inc. Product
Table 125. Thermo Fisher Scientific, Inc. Revenue in Companion Diagnostic Tests Business (2015-2020) (Million US$)
Table 126. Thermo Fisher Scientific, Inc. Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Companion Diagnostic Tests Market Share by Type: 2020 VS 2026
Figure 2. Protein Detection Features
Figure 3. DNA Detection Features
Figure 4. Hybridization Features
Figure 5. Biomarker Features
Figure 6. Others Features
Figure 7. Global Companion Diagnostic Tests Market Share by Application: 2020 VS 2026
Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
Figure 9. Medical Device Companies Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Companion Diagnostic Tests Report Years Considered
Figure 12. Global Companion Diagnostic Tests Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Companion Diagnostic Tests Market Share by Regions: 2020 VS 2026
Figure 14. Global Companion Diagnostic Tests Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Companion Diagnostic Tests Market Share by Players in 2019
Figure 17. Global Top Companion Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests Revenue in 2019
Figure 19. North America Companion Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Companion Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Companion Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Companion Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Companion Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Companion Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Companion Diagnostic Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. F. Hoffman LA Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. F. Hoffman LA Roche Ltd. Revenue Growth Rate in Companion Diagnostic Tests Business (2015-2020)
Figure 28. QIAGEN, Illumina, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. QIAGEN, Illumina, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2015-2020)
Figure 30. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Abbott Revenue Growth Rate in Companion Diagnostic Tests Business (2015-2020)
Figure 32. Agilent Technologies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Agilent Technologies, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2015-2020)
Figure 34. Genomic Health, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Genomic Health, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2015-2020)
Figure 36. BioMerieux SA, BioGenex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. BioMerieux SA, BioGenex Revenue Growth Rate in Companion Diagnostic Tests Business (2015-2020)
Figure 38. AGENDIA NV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. AGENDIA NV Revenue Growth Rate in Companion Diagnostic Tests Business (2015-2020)
Figure 40. Siemens Healthcare GmBH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Siemens Healthcare GmBH Revenue Growth Rate in Companion Diagnostic Tests Business (2015-2020)
Figure 42. Thermo Fisher Scientific, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed